Text this: EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION